ES2191152T3
(es )
2003-09-01
Terapia combinada para el tratamiento de psicosis.
CY1108610T1
(el )
2014-04-09
Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE69728585D1
(de )
2004-05-13
Mittel gegen Juckreiz
PT960107E
(pt )
2003-02-28
Compostos de paclitaxel 6-tio-substituidos
ES2190246T3
(es )
2003-07-16
Nuevos compuestos de tiazolopirimidina.
IL163573A0
(en )
2005-12-18
Conjugates of therapeutic or cytotoxic agents and biologically active peptides
BR0207961A
(pt )
2004-04-20
Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
IL138476A0
(en )
2001-10-31
Method for treating pharmaceutical compositions by special use of anti-oxidant
AR016981A2
(es )
2001-08-01
Polipeptidos sinteticos
NO20005885L
(no )
2001-01-17
Kombinasjonsterapi for behandling av refraktær depresjon
DE69840415D1
(de )
2009-02-12
Haemasterlin analoge
SE9904377D0
(sv )
1999-12-01
Pharmaceutical combinations
ES2167678T3
(es )
2002-05-16
Tratamiento y profilaxis de la pancreatitis.
AR022321A1
(es )
2002-09-04
Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
GB0207653D0
(en )
2002-05-15
Methods of using lamellar bodies for therapeutic purposes
PT853959E
(pt )
2003-03-31
Composicao para o tratamento do amianto
ITMI991605A0
(it )
1999-07-21
Follatore per il trattamento di cuoio pelli e simili
DK1133296T3
(da )
2003-11-17
Ny terapeutisk anvendelse af nicergolin
NO20005548D0
(no )
2000-11-03
Mykobakterieinhibitorer
ECSP972266A
(es )
1998-11-23
Terapia de combinacion para el tratamiento de psicosis
IT1289154B1
(it )
1998-09-29
Derivati di isoflavone loro preparazione e loro impiego terapeutico
IL143279A0
(en )
2002-04-21
Novel therapeutic application of low molecular weight heparin
ATE250340T1
(de )
2003-10-15
7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
DK1133297T3
(da )
2003-11-24
Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
AP9600780A0
(en )
1997-08-05
Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.